Currently, there are 908.48M common shares owned by the public and among those 902.41M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -4.32% and -17.94% over the past three months. RF shares are trading -4.93% year to date (YTD), with the 12-month market performance up to 20.02% higher. It has a 12-month low price of $17.72 and touched a high of $27.96 over the same period. RF has an average intraday trading volume of 8.02 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.45%, -6.73%, and -1.89% respectively.
Institutional ownership of Regions Financial Corp (NYSE: RF) shares accounts for 81.73% of the company’s 908.48M shares outstanding.
It has a market capitalization of $20.25B and a beta (3y monthly) value of 1.02. The stock’s trailing 12-month PE ratio is 11.57, while the earnings-per-share (ttm) stands at $1.93. The company has a PEG of 1.40 and the debt-to-equity ratio at 0.39. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.84% over the week and 2.21% over the month.
Earnings per share for the fiscal year are expected to increase by 6.60%, and 10.33% over the next financial year. EPS should grow at an annualized rate of 8.24% over the next five years, compared to 5.13% over the past 5-year period.
Looking at the support for the RF, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on December 09, 2024, with the firm’s price target at $28-$32. Keefe Bruyette coverage for the Regions Financial Corp (RF) stock in a research note released on October 31, 2024 offered a Outperform rating with a price target of $28. Stephens was of a view on October 29, 2024 that the stock is Overweight, while Deutsche Bank gave the stock Buy rating on October 24, 2024, issuing a price target of $24- $26. Argus on their part issued Buy rating on October 24, 2024.
